mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.14 |
0.002 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |